Investor Presentation

July 31, 2026 To, To, National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, BKC P.J. Towers, Bandra-Kurla Complex, 25th Floor, Dalal Street, Fort Bandra (East), Mumbai-400 051 Mumbai 400 001 Symbol: JLHL Code: 543980 Subject: Investor Presentation for the quarter ended June 30, 2026. Reference: Unaudited Financial Results for the quarter ended June 30, 2026 (Standalone and Consolidated) of the Company. Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended from time to time, please find the enclosed investor presentation for the Unaudited (Standalone and Consolidated) Financial Results for the quarter ended June 30, 2026. The same will be available on the website of the Company at www.jupiterhospital.com You are requested to kindly take the afore mentioned on record and oblige. Thanking you, For JUPITER LIFE LINE HOSPITALS LIMITED Suma Upparatti Company Secretary & Compliance Officer CARE THAT Trusted. Tested. MOVES FORWARD, Transforming. EVERY YEAR. Investor Presentation July 2026 Investor Presentation July 2026 Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Jupiter Life Line Hospitals Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. This presentation contains certain forward looking statements concerning the Company’s future business prospects and business profitability, which are subject to a number of risks and uncertainties and the actual results could materially differ from those in such forward looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, competition (both domestic and international), economic growth in India and abroad, ability to attract and retain highly skilled professionals, time and cost over runs on contracts, our ability to manage our international operations, government policies and actions regulations, interest and other fiscal costs generally prevailing in the economy. The Company does not undertake to make any announcement in case any of these forward looking statements become materially incorrect in future or update any forward looking statements made from time to time by or on behalf of the Company. Management Commentary P a t i e n t F i r s t “Our Dombivli hospital completed its first full quarter of operations, occupancy has been increasing steadily, supported by increasing patient footfall, expansion of clinical services and growing patient acceptance. The EBITDA loss from Dombivli of 9.5 crore in this quarter is in line with internal projections and earlier guidance. We have also initiated process of insurance empanelment, which is expected to further improve patient inflows in the coming quarters. In line with our phased development strategy, we continue to add new specialties, strengthen our consultant base and expand service offerings to support a steady ramp-up. Pune South, Mira Road and BKC projects are continuing progress as discussed earlier. Our established hospitals continue to maintain healthy occupancy levels, providing a stable financial and operational base.” Dr. Ankit Thakker MD & CEO Q1FY27 Performance Highlights Rs in Cr Total Income EBITDA PBT PAT 411.0 78.4 79.3 61.7 43.9 353.0 37.5 50.6 320.0 274.8 72.6 63.1 15.1 18.4 Q1FY26 Q1FY27 Q1FY26 Q1FY27 Q1FY26 Q1FY27 Q1FY26 Q1FY27 IPD OPD Others • EBITDA impacted by initial ramp-up loss of Rs 9.5 cr in Dombivli and higher marketing costs on account of launch related activities • Higher depreciation following commercialisation of Dombivli hospital • Higher finance costs owing to an increase in debt for ongoing capex Q1FY27 Operating Metrics Operational Bed Capacity(1) Average Occupancy Rate(2) IPD & OPD Volumes (‘000)(3) Excluding 61.7% Census Beds Non - Census Beds Dombivli 60.1% 59.6% Hospital 291.5 1,259 259.1 14.2 1,061 IPD 13.3 1,063 929 OPD 245.8 277.3 132 196 Q1FY26 Q1FY27 Q1FY26 Q1FY27 Q1FY26 Q1FY27 ARPOB(4) ALOS (in Days)(5) Payor Mix Government Schemes Self Payors Insurance Companies 73,500 67,300 3.78 3.76 1.4% 0.9% 42.3% 44.4% 56.3% 54.7% Q1FY26 Q1FY27 Q1FY26 Q1FY27 Q1FY26 Q1FY27 ARPOB rounded off to the nearest hundred 1) Operational beds includes census beds (bed available for mid-night occupancy such as intensive care units (“ICUs”), wards etc.) and non-census beds (all other bed available other than census beds, such as day-care beds, casualty beds etc.) (2) Average occupancy rate is calculated as census occupied bed days (i.e. midnight census of occupied census beds during the period) divided by available census bed days (i.e. census bed capacity multiplied by the applicable days in the relevant period) (3) Out-patient volume refers to the total number of Out-patient bills generated in a specific period. Inpatient volume refers to the total number of inpatient discharge in a specific period irrespective of admission date. (4) ARPOB is calculated as income from hospital services divided by census occupied bed days (i.e. midnight census of occupied census beds during the period) (5) ALOS is the average length of stay of patients in a specific period, calculated as census occupied bed days (i.e. midnight census of occupied census beds during the period) divided by inpatient volume. Consolidated Profit & Loss Statement Profit and Loss (in Rs. Crs) Q1FY27 Q1FY26 YoY Q4FY26 QoQ FY26 Revenuefrom Operations 392.6 337.9 16.2% 371.7 5.6% 1,435.6 Other Income - Operational 18.4 15.0 16.1 64.2 Total Income 411.0 352.9 16.4% 387.8 6.0% 1,499.8 Cost of Goods Sold 80.0 70.7 73.7 287.3 Gross Profit 331.0 282.2 17.3% 314.1 5.4% 1,212.5 • EBITDA includes an operational Gross Profit Margin 80.5% 80.0% 81.0% 80.8% loss of Rs 9.5 cr and Rs 9.4 cr Employee Cost 74.5 61.7 67.7 256.3 from Dombivli Hospital for Professional Fees 102.2 82.7 91.6 364.0 Q1FY27 and Q4FY26 Other Expenses 75.0 59.4 65.6 248.9 respectively during the initial ramp-up phase EBITDA 79.3 78.4 1.1% 89.2 -11.1% 343.3 EBITDA Margin 19.3% 22.2% 23.0% 22.9% • Depreciation has increased due Depreciation 26.4 21.2 23.3 87.6 to capitalisation of newly added EBIT 52.9 57.2 -7.5% 65.9 -19.8% 255.6 beds EBIT Margin 12.9% 16.2% 17.0% 17.0% Other Income - Finance 10.6 12.8 9.1 42.4 • Finance cost increased on Finance Cost 12.9 8.3 9.0 32.7 account of debt taken for Exceptional Item Gain / (Loss)* 0.0 0.0 1.5 -4.9 expansion projects PBT 50.6 61.7 -18.1% 67.5 -25.0% 260.4 PBT Margin 12.3% 17.5% 17.4% 17.4% Tax 13.1 17.8 17.3 66.2 PAT 37.5 43.9 -14.7% 50.2 -25.3% 194.2 PAT Margin 9.1% 12.5% 12.9% 12.9% Basic EPS 5.72 6.69 7.66 29.59 *Statutory impact of New Labour codes Next-Phase of Growth: Scaling Bed Capacity from 1,700 to 2,900 Capex/Bed Hospitals Bed Capacity Remarks (Excl. Land) (Rs in cr) Recently Commissioned Dombivli 500 1.0 Phase-wise commissioning underway, with ~200 beds operational and fit-outs completed for an additional 100 beds Greenfield Pune II [Showing first 8,000 characters — download PDF for full document]